US FDA widens use of Roche eye drug for diabetics

WASHINGTON, Aug 11: US drug regulators gave the nod to a wider use for Roche Holding AG�s eye drug Lucentis, approving it for diabetic patients with a vision-robbing eye condition. Lucentis, made by Roche unit Genentech, is already prescribed for two other eye ailments. (agencies)